Having trouble accessing articles? Reset your cache.

Zerenex ferric citrate: Phase III started

Keryx began an open-label, international Phase III trial to evaluate oral Zerenex in about 300

Read the full 152 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE